Observational Study
Copyright ©The Author(s) 2025.
World J Crit Care Med. Sep 9, 2025; 14(3): 106496
Published online Sep 9, 2025. doi: 10.5492/wjccm.v14.i3.106496
Table 5 Diagnostic performance of serum procalcitonin and combined sepsis screening tools and procalcitonin
Parameters
PCT 0.85 μg/L
PCT 0.50 μg/L
qSOFA 2 + PCT 0.85 μg/L
SIRS 2 + PCT 0.85 μg/L
Sensitivity77% (58-90)77% (58-90)72% (51-88)76% (56-90)
Specificity48% (28-69)24% (9-45)44% (22-69)48% (28-69)
False negative rate23% (10-42)23% (10-42)28% (12-49)24% (10-44)
False positive rate52% (31-72)76% (55-91)56% (31-78)52% (31-72)
Positive likelihood ratio1.47 (0.96-2.26)1.01 (0.75-1.36)1.30 (0.80-2.09)1.46 (0.95-2.24)
Negative likelihood ratio0.49 (0.23-1.05)0.97 (0.38-2.52)0.63 (0.28-1.42)0.50 (0.23-1.08)
Diagnostic odds ratio3.03 (0.96-9.62)1.04 (0.30-3.69)2.06 (0.57-7.36)2.90 (0.91-9.23)
Youden’s index0.25 (0.00-0.49)0.01 (-0.22 to 0.23)0.16 (-0.12 to 0.45)0.24 (-0.01 to 0.49)